The Reported Adverse Effects Related to Biological Agents Used for the Treatment of Rheumatic Diseases in Turkey
Erkan Kılıç(Ministry of Health), Salih Özgöçmen(Tokat Gaziosmanpaşa Üniversitesi), Gamze Kılıç(Karadeniz Technical University), Gürkan Akgöl(Fırat University), Özgür Akgül(Erciyes University)
Cited by 6
Related Papers
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
|Annals of the Rheumatic Diseases|2017|1.6k
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
|Annals of the Rheumatic Diseases|2011|988
Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study
|Annals of the Rheumatic Diseases|2015|268
Role of antioxidant systems, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis
|Molecular and Cellular Biochemistry|2006|204
Relationship between psychological status and disease activity and quality of life in ankylosing spondylitis
|Rheumatology International|2010|140